Orrstown Financial Services »

Outlook Therapeutics shares owned by Orrstown Financial Services

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Orrstown Financial Services from 13F filings

Historical chart of Orrstown Financial Services investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Orrstown Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Orrstown Financial Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $24k 15k 1.59

More positions owned by Orrstown Financial Services

iShares Core S&P 500 Index Fund Exchange Traded Fund (IVV)
Vanguard Core Bond Fixed Income ETF (VCRB)
JPMorgan Active Value Exchange Traded Fund (JAVA)
Fidelity Enhanced International International Equity ETF (FENI)
Avantis U.S. Small Cap Value Exchange Traded Fund (AVUV)
Goldman Sachs Small Cap Equity Exchange Traded Fund (GSC)
JPMorgan Equity Premium Income Exchange Traded Fund (JEPI)
JPMorgan Active Growth Exchange Traded Fund (JGRO)
JPMorgan Hedged Equity Laddered Overlay Exchange Traded Fund (HELO)
Vanguard Intermediate Term Bond ETF Fixed Income ETF (BIV)
Alphabet Common Stock (GOOGL)
Apple Common Stock (AAPL)
NVIDIA Corp Common Stock (NVDA)
iShares Core MSCI EAFE ETF International Equity ETF (IEFA)
Microsoft Corp Common Stock (MSFT)

View all positions for Orrstown Financial Services

Top funds holding Outlook Therapeutics

Armistice Capital
Vanguard Capital Management
Gilpin Wealth Management
Geode Capital Management
BlackRock
Warberg Asset Management
Renaissance Technologies
Connective Capital Management
Citadel Advisors
Susquehanna International
Vanguard Fiduciary Trust
State Street Corporation
UBS Group
Simplex Trading
Group One Trading

View all funds holding Outlook Therapeutics